title: [Recent advances in studies of clinical treatment of uveitis].
abstract: Uveitis is a common immune-related intraocular inflammation, the topical or systemic corticosteroids are the first-line drugs for the treatment of uveitis. The combined immunomodulatory agents of cyclosporine, mycophenolate mofetil, azathioprine or cyclophosphamide are helpful for the treatment of severe or refractory uveitis. The new biologic agents, tumor necrosis factor inhibitors, interferon alpha or the interleukin-2 receptor antagonists, are also helpful for certain types of refractory uveitis. Intravitreal steroids injection or vitrectomy would be beneficial for specific types of uveitis and their complications. The advances of uveitis treatment in recent years are reviewed.
authors.affiliation: Tianjin Eye Hospital, Clinical College of Ophthalmology, Tianjin Medical University, Tianjin 300020, China. eye2002@163.com
authors.forename: Yue-zhong
authors.initials: YZ
authors.lastname: Zheng
mesh_terms: D006801:Humans; D014605:Uveitis / Q000628:therapy*